Get research updatesPublic study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study has finished and is no longer accepting participants.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In Bulgaria
A Pragmatic Cluster Randomized Controlled Trial of a Multi-element Psychosocial Intervention for Early Psychosis in a 10 Million Inhabitant Catchment Area Aimed to Measure the Treatment's Feasibility and Effectiveness: GET UP-PIANO Trial
This study has finished and is no longer accepting participants.
In VeronaThis study has finished and is no longer accepting participants.
Multiple locations, including ClevelandThis study has finished and is no longer accepting participants.
In BaltimoreResearchers studied atomoxetine, tracking side effects to assess long-term safety and tolerability in adults with ADHD.
This study has finished and is no longer accepting participants.
Multiple locations, including AichiThis study has finished and is no longer accepting participants.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In Czech RepublicAn Open, Self-Controlled, Prospective Study of Concerta on Cognitive Functions, Efficacy and Tolerance in the Pediatric Patients With Attention Deficit Hyperactivity Disorder (ADHD)
This study has finished and is no longer accepting participants.
Multiple locations, including BeijingMaintenance of Response After Open-Label Treatment With Atomoxetine Hydrochloride in Adult Outpatients With Attention-Deficit/Hyperactivity Disorder (ADHD): A Placebo-Controlled, Randomized Withdrawal Study
This study has finished and is no longer accepting participants.
Multiple locations, including ViennaAn Open Extension Study to Phase IIb Study of Clozapine in Patients With Treatment-resistant Schizophrenia
This study has finished and is no longer accepting participants.
Location not clearly listedAn Open Label, Long Term Trial of Risperidone Long Acting Microspheres in the Treatment of Patients Diagnosed With Schizophrenia
This study has finished and is no longer accepting participants.
Location not clearly listedRisperidone Depot (Microspheres) in the Treatment of Subjects With Schizophrenia or Schizoaffective Disorder - an Open Label Follow up Trial of RIS-INT-57 and RIS-INT-61.
This study has finished and is no longer accepting participants.
Location not clearly listedResearchers studied OPC-34712FUM/ Brexpiprazole fumarate, tracking side effects to assess long-term safety and tolerability in people with schizophrenia.
This study has finished and is no longer accepting participants.
In Kure-shiWe gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.